XML 45 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation (Details) (USD $)
6 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Stock Options [Member]
Sep. 30, 2013
Stock Options [Member]
Mar. 31, 2014
Stock Options [Member]
Sep. 30, 2014
Stock Options [Member]
Executive Employees and Directors [Member]
Sep. 30, 2014
Stock Options [Member]
Non-Executive Employees [Member]
Sep. 30, 2014
Restricted Stock [Member]
Sep. 30, 2014
Restricted Stock [Member]
Mar. 31, 2014
Restricted Stock [Member]
Sep. 30, 2014
Restricted Stock [Member]
Minimum [Member]
Sep. 30, 2014
Restricted Stock [Member]
Maximum [Member]
Sep. 30, 2014
2006 Amended Stock and Incentive Plan [Member]
Plan
Sep. 30, 2014
2006 Amended Stock and Incentive Plan [Member]
Stock Options [Member]
Sep. 30, 2014
2006 Amended Stock and Incentive Plan [Member]
Stock Options [Member]
Minimum [Member]
Sep. 30, 2014
2006 Amended Stock and Incentive Plan [Member]
Stock Options [Member]
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Number of active plans for share-based compensation grants                         1      
Number of shares reserved for share-based grants (in shares)                         3,450,000      
Shares available for grant (in shares)                         360,531      
Term of share-based payment award                     3 years 4 years     5 years 7 years
Vesting period                           3 years    
Share-based compensation expense $ 661,000 $ 921,000                            
Weighted-average assumptions used to value the options granted [Abstract]                                
Expected life in years     2 years 9 months 22 days 4 years 6 months 4 days                        
Risk free interest rate (in hundredths)     1.00% 1.35%                        
Expected volatility (in hundredths)     66.41% 89.43%                        
Expected dividend yield (in hundredths)     0.00% 0.00%                        
Weighted-average grant date fair value (in dollars per share)     $ 1.21 $ 1.65                        
Forfeiture rate (in hundredths)           0.00% 18.00%                  
Stock options, number of shares [Roll Forward]                                
Outstanding, beginning of period (in shares)     2,328,043                          
Options granted (in shares)     131,300                          
Options exercised (in shares)     (85,000)                          
Options surrendered (in shares)     (163,018)                          
Outstanding, end of period (in shares)     2,211,325   2,328,043                      
Exercisable, end of period (in shares)     1,402,997                          
Stock options, weighted average exercise price [Roll Forward]                                
Outstanding, beginning of period (in dollars per share)     $ 3.39                          
Options granted (in dollars per share)     $ 2.98                          
Options exercised (in dollars per share)     $ 0.80                          
Options surrendered (in dollars per share)     $ 5.02                          
Outstanding, end of period (in dollars per share)     $ 3.34   $ 3.39                      
Exercisable, end of period (in dollars per share)     $ 3.74                          
Stock options, additional disclosures [Abstract]                                
Outstanding, weighted average remaining life in years     3 years 9 months   3 years 10 months 6 days                      
Exercisable, Weighted average remaining life in years     2 years 6 months                          
Outstanding, aggregate intrinsic value, end of period     117,780   1,781,415                      
Exercisable, aggregate intrinsic value, end of period     39,994                          
Fair value of stock options vested     620,000 315,000                        
Restricted shares, number of shares [Roll Forward]                                
Balance, beginning of period (in shares)                 146,262              
Shares granted (in shares)                 405,625              
Shares vested (in shares)                 (50,436)              
Shares forfeited (in shares)                 (9,212)              
Balance, end of period (in shares)               492,239 492,239 146,262            
Restricted shares, weighted average grant date fair value [Roll Forward]                                
Balance, beginning of period (in dollars per share)                 $ 3.38              
Shares granted (in dollars per share)                 $ 3.25              
Shares vested (in dollars per share)                 $ 3.57              
Shares forfeited (in dollars per share)                 $ 3.94              
Balance, end of period (in dollars per share)               $ 3.24 $ 3.24 $ 3.38            
Restricted shares, additional disclosures [Abstract]                                
Weighted average remaining life in years                 2 years 2 months 12 days 2 years 2 months 23 days            
Outstanding, Aggregate intrinsic value               1,230,598 1,230,598 540,000            
Unrecognized share-based compensation expense     $ 1,161,000         $ 1,353,000 $ 1,353,000              
Unrecognized compensation expense, weighted average period of recognition     1 year 10 months 24 days         2 years 2 months 12 days